Page last updated: 2024-08-17

3,3'-diaminobenzidine and HIV Coinfection

3,3'-diaminobenzidine has been researched along with HIV Coinfection in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mitarnun, W; Nittayananta, W; Sriplung, H; Talungchit, S1

Other Studies

1 other study(ies) available for 3,3'-diaminobenzidine and HIV Coinfection

ArticleYear
Changes in oral cytokeratin expression in HIV-infected subjects with long-term use of HAART.
    Oral diseases, 2012, Volume: 18, Issue:8

    Topics: 3,3'-Diaminobenzidine; Adult; Alcohol Drinking; Antiretroviral Therapy, Highly Active; Biopsy, Needle; CD4 Lymphocyte Count; Chromogenic Compounds; Cross-Sectional Studies; Epithelial Cells; Female; HIV; HIV Infections; HIV Seropositivity; Humans; Keratin-1; Keratin-13; Keratin-14; Keratin-16; Keratins; Male; Middle Aged; Mouth Mucosa; Protein Precursors; Smoking; Viral Load; Young Adult

2012